EP Patent

EP1030704A1 — Inhalation device

Assigned to AstraZeneca UK Ltd · Expires 2000-08-30 · 26y expired

What this patent protects

An actuator for an inhaler for administering medicament by inhalation, comprising: a main body (102) comprising an elongate tubular member (108) for receiving a canister (107) containing medicament and having a valve stem (111) extending therefrom, the tubular member (108) includ…

USPTO Abstract

An actuator for an inhaler for administering medicament by inhalation, comprising: a main body (102) comprising an elongate tubular member (108) for receiving a canister (107) containing medicament and having a valve stem (111) extending therefrom, the tubular member (108) including a lateral opening (114) at one end thereof; and an outlet assembly (104) comprising a mouthpiece for guiding medicament to the mouth of a user and a nozzle block (120) for receiving the valve stem (111) of the canister (107) and delivering medicament from the canister (107) into the mouthpiece, the outlet assembly (104) being detachably mounted, through the lateral opening (114), to the main body (102) at an angle transverse to the length of the tubular member (108); characterized in that one of the main body (102) and the outlet assembly (104) further comprises at least one resiliently biased member, which is configured to engage with at least one part of the other of the main body (102) and the outlet assembly (104) and thereby hold the outlet assembly (104) to the main body (102), and at least one release component which in use is acted upon to enable release of the outlet assembly (104) from the main body (102).

Drugs covered by this patent

Patent Metadata

Patent number
EP1030704A1
Jurisdiction
EP
Classification
Expires
2000-08-30
Drug substance claim
No
Drug product claim
No
Assignee
AstraZeneca UK Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.